This dysfunction is often driven by the upregulation of inhibitory receptors such as CD96 and T cell immunoreceptors with Ig and ITIM domains (TIGIT), and by immunosuppressive cytokines like TGF-β1 within the tumor niche [109,110,120]. This evidence concerns the gene TGFB1 and neoplasm.